My ePortfolio Register   

Do variations in prognostic risk stratification criteria for patients with gastrointestinal stromal tumours affect adjuvant treatment?

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 05.07.17
Views: 619

Dr Fahad Ibnshamsah - King Fahad Specialist Hospital, Dammam, Saudi Arabia

Dr Ibnshamsah talks with ecancer at ESMO GI 2017 about gastrointestinal stromal tumour and the retrospective study looking into the decisions being made for adjuvant therapy according to the armed forces institute of pathology’s criteria for risk stratification.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence